Real-World Comparative Evaluation of Add-On Glucagon-like Peptide 1 Receptor Agonist in Type 2 Diabetes Treated with or without Insulin

• 主要な著者: Hsuan-Wen Chou (著者), Kai-Pi Cheng (著者), An-Chi Lin (著者), Hao-Chang Hung (著者), Ching-Han Lin (著者), Chih-Chen Wang (著者), Hung-Tsung Wu (著者), Horng-Yih Ou (著者)
• フォーマット: 図書
• 出版事項: MDPI AG, 2022-12-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Glucagon-like peptide 1 receptor agonist (GLP-1 RA) is a potent antidiabetic agent with cardiorenal and weight-losing benefits in patients with type 2 diabetes (T2D). The combination of GLP-1 RA with basal insulin has been suggested in several clinical studies as a useful treatment for intensifying...